{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03988335",
      "orgStudyIdInfo": {
        "id": "RIST4721-201"
      },
      "organization": {
        "fullName": "Aristea Therapeutics, Inc.",
        "class": "INDUSTRY"
      },
      "briefTitle": "A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)",
      "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects With Palmoplantar Pustulosis"
    },
    "descriptionModule": {
      "briefSummary": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis"
    },
    "conditionsModule": {
      "conditions": [
        "Palmoplantar Pustulosis"
      ],
      "keywords": [
        "PPP"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "DOUBLE",
          "maskingDescription": "Double-blind",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 35,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "RIST4721",
          "type": "EXPERIMENTAL",
          "description": "RIST4721 as once-daily 300mg oral solution for 28 days.",
          "interventionNames": [
            "Drug: RIST4721"
          ]
        },
        {
          "label": "Placebo",
          "type": "PLACEBO_COMPARATOR",
          "description": "Placebo as once-daily 300mg oral solution for 28 days.",
          "interventionNames": [
            "Drug: Placebo"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "RIST4721",
          "description": "RIST4721 oral solution",
          "armGroupLabels": [
            "RIST4721"
          ]
        },
        {
          "type": "DRUG",
          "name": "Placebo",
          "description": "Placebo oral solution",
          "armGroupLabels": [
            "Placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Log Transformed Ratio of Postbaseline Fresh Pustule Count at Day 28 to Baseline",
          "description": "Relative change from baseline in fresh pustule count at Day 28",
          "timeFrame": "Baseline to Day 28"
        },
        {
          "measure": "Log Transformed Ratio of Postbaseline Total Pustule Count at Day 28 to Baseline",
          "description": "Relative change from baseline in total pustule count at Day 28",
          "timeFrame": "Baseline to Day 28"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* At least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles\n* Moderate or severe PPP, as defined by Palmoplantar Pustulosis Psoriasis Area and Severity Index (PPPASI) ≥8 and Palmoplantar Pustulosis Physician Global Assessment (PPPGA) ≥3 at Day -1, and a minimum of 8 fresh pustules at screening (fresh pustule count on both right/left palms and soles) and 20 fresh pustules at Day -1 (fresh pustule count on both right/left palms and soles)\n* Males and females must be willing to use birth control as indicated\n\nExclusion Criteria:\n\n* Moderate to severe psoriasis, as defined by plaque psoriasis covering ≥10% of total Body Surface Area (BSA) at Day -1\n* Subject is known to have an immune deficiency or is immunocompromised\n* Positive test for hepatitis, human immunodeficiency virus (HIV) or tuberculosis\n* Use of topical therapies for PPP within 2 weeks of Day -1 and/or systemic therapies for PPP within 4 weeks",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "70 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    }
  }
}